WW
VRTX icon

Westshore Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Westshore Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000
Closed -$783K – 112
2022
Q1 		$783K Sell
3,000
-100
-3% -$23.7K 0.53% 26
2021
Q4 		$681K Buy
+3,100
New +$603K 0.47% 29

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Westshore Wealth's VRTX Position: Q2 2022 in Review

Westshore Wealth sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 3,000 shares — an estimated $783K sold.

Westshore Wealth first reported a position in VRTX in Q4 2021 and held it in 2 quarters. The position peaked at $783K in Q1 2022. 1,107 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.

  • Westshore Wealth reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Westshore Wealth sold 3,000 Vertex Pharmaceuticals shares in Q2 2022, an estimated $783K.
  • Westshore Wealth first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Westshore Wealth's Vertex Pharmaceuticals position peaked at $783K in Q1 2022.
  • 1,107 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.

Based on Westshore Wealth's 13F filing for Q2 2022, filed 15 Jul 2022.